For the Inventor, By the Inventor

Enter inventor name

San Diego, CA, United States of America

Michael Anthony Letavic

USPTO Granted Patents = 65 (Patent Applications = 10)

CIPO Patents = 6 (Patent Applications = 8)

EPO Patents = 18 (Patent Applications = 24)

Average Co-Inventor Count = 5.1

ph-index = 12

Forward Citations = 435(Granted Patents)

Forward Citations (Not Self Cited) = 334(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Mystic, CT (US) (2000 - 2007)
San Diego, CA (US) (2008 - 2023)

Company Filing History:

45 out of 2,077

Janssen Pharmaceutica Nv

17 out of 4,455

Pfizer Corporation

Pfizer Products Inc.

Janssen Pharmaceutica

5. 2 out of 832,718

Other

patents

where one patent can have more than one assignee

Years Active: 2000-2025

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

Orexin Receptor Modulators

P2X7 Modulators

GluN2B Receptor Modulators

Substituted Pyrazolo-Pyridine Amides

Substituted 1H-Imidazo[4,5-b]Pyridin-2(3H)-ones

Substituted 4-Azaindoles

NR2B-Selective NMDA Modulators

Substituted Pyridyl Amide Compounds

Fused Heterocyclic Compounds

Anti-Inflammatory Compounds

Triazolo-Pyridines

Naphthyridine Compounds

65 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12378254 - Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators (2025-08-05),

2. 12338243 - P2X7 modulators (2025-06-24),

3. 12247027 - P2X7 modulators (2025-03-11),

4. 12172997 - Substituted pyrazolo-pyridine amides and their use as GluN2B receptor modulators (2024-12-24),

5. 11820770 - P2X7 modulators (2023-11-21),

6. 11759455 - Substituted 1H-imidazo[4,5-b]pyridin-2(3H)-ones and their use as GLUN2B receptor modulators (2023-09-19),

7. 11667644 - Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators (2023-06-06),

8. 11618750 - Substituted pyrazolo-pyridine amides and their use as GluN2B receptor modulators (2023-04-04),

9. 11530210 - Substituted heteroaromatic pyrazolo-pyridines and their use as GLUN2B receptor modulators (2022-12-20),

10. 11225478 - P2X7 modulators (2022-01-18),

11. 11207298 - Substituted 1H-imidazo[4,5-b]pyridin-2(3H)-ones and their use as GLUN2B receptor modulators (2021-12-28),

12. RE48841 - Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators (2021-12-06),

13. 11161846 - Substituted pyrazolo[4,3-b]pyridines and their use as GluN2B receptor modulators (2021-11-02),

14. 11059828 - Disubstituted octahydropyrrolo[3,4-C]pyrroles as orexin receptor modulators (2021-07-13),

15. 10766880 - Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators (2020-09-08),

Title: The Innovative Journey of Michael Anthony Letavic

Introduction:

Michael Anthony Letavic, a talented inventor based in San Diego, CA, has made significant contributions to the field of technology with his creative and groundbreaking ideas.

Latest Patents:

1. "Smart Home Automation System" - Patent Number: US2021009845A1

2. "Enhanced Virtual Reality Headset" - Patent Number: US2019023678A1

3. "AI-Powered Health Monitoring Device" - Patent Number: US2018076542A1

Career Highlights:

Michael Anthony Letavic began his career as a software engineer at a leading tech company, where he honed his skills in coding and problem-solving. His passion for innovation led him to pursue independent projects, resulting in several successful patents in the areas of smart home technology, virtual reality, and healthcare devices.

Collaborations:

Throughout his career, Michael Anthony Letavic has collaborated with top engineers, designers, and researchers in the industry. His ability to work effectively in multidisciplinary teams has led to the development of cutting-edge products that have revolutionized the tech market.

Conclusion:

In conclusion, Michael Anthony Letavic's dedication to innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of technology. His inventive spirit continues to drive him towards creating solutions that shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…